[The role of sleep in ADHD: Possibilities for prevention of ADHD?].

[The role of sleep in ADHD: Possibilities for prevention of ADHD?].

Tijdschr Psychiatr. 2013;55(10):773-82

Authors: Arns M

Abstract
BACKGROUND: Personalized medicine aims to provide the right treatment for the right person at the right time, as opposed to the currently employed &lsquo;one-size-fits-all&rsquo; approach. This development relies on identification of <span class=”abbreviation”>adhd</span> subgroups using biomarkers. One important <span class=”abbreviation”>adhd</span> subgroup is characterised by impaired vigilance regulation, as quantified by the <span class=”abbreviation”>eeg</span> and this sub-group responds well to stimulant medication and neurofeedback. Recent insights suggest a clear association between reduced sleep duration and <span class=”abbreviation”>adhd</span> complaints in this sub-group of <span class=”abbreviation”>adhd</span> patients. A recently published model explains how different treatments e.g. chronobiological treatments and neurofeedback impact on this neural circuitry and mediate <span class=”abbreviation”>adhd</span> symptom improvement.
AIM: To test this recently published model predicting a relationship between solar intensity and <span class=”abbreviation”>adhd</span> prevalence.
METHOD: A literature survey on studies using identical methods to estimate the prevalence of <span class=”abbreviation”>adhd</span> in different geographical areas and compare those to worldwide solar intensity data.
RESULTS: A clear relationship between solar intensity and the worldwide prevalence of <span class=”abbreviation”>adhd</span> was found, explaining 34-57% of the variance in <span class=”abbreviation”>adhd</span> prevalence, where a lower prevalence of <span class=”abbreviation”>adhd</span> was found in areas with high solar-intensity.
CONCLUSION: The preventative effect of high solar intensity may be related to improvement of circadian clock disturbances. These findings likely apply to a substantial sub-group of <span class=”abbreviation”>adhd</span> patients and have major implications for our understanding of the etiology and possibly prevention of <span class=”abbreviation”>adhd</span>.

PMID: 24166337 [PubMed – in process]

via http://www.ncbi.nlm.nih.gov/pubmed/24166337?dopt=Abstract